You Need to Have an Abnormal Haemoglobin to Have a Haemoglobinopathy. Or Do You?
Daniel Pereira Monteiro, NHSE Screening Professional Clinical Advisor, posted on LinkedIn:
”You need to have an abnormal haemoglobin (variant) to have a haemoglobinopathy. Or do you?
Let’s test your interpretation skills
How would you report this case? Does it need any further testing?
Welcome to the Haemopaedia Case of the Week
A quick haemoglobinopathy interpretation challenge designed to support your weekly CPD.
Drop your interpretation below – I’ll share the answer on Friday so everyone has time to participate.
If you’d like to receive updates about upcoming training sessions, webinars and case-based learning, you can join my Training Hub list here.
You can unsubscribe at any time.
Have a case you’d like featured? DM me to share an anonymised example for future posts.
Bio-Rad Laboratories
Institute of Biomedical Science
Disclaimer:
All cases shared in these series are for educational purposes only and do not constitute clinical or diagnostic advice.
Contributors are reminded to ensure all examples are fully anonymised and shared in accordance with their local governance and confidentiality policies.”

Keep up with Hemostasis Today.
-
Jun 3, 2026, 04:12Lynne Baird: Why Bleed Control Kits Belong in Every Public Space
-
Jun 2, 2026, 19:42Sékouba Sidimé: vWD vs Hemophilia A – The Classic USMLE Step 1 trap in Hematology
-
Jun 2, 2026, 19:41Bassem M. Mohammed: How Factor VIII Interacts To Procoagulant Membranes To Support Activation Of Blood Clotting
-
Jun 2, 2026, 19:28Looking Beyond Bleeding Control To Understand Inflammation In Hemophilic Arthropathy – CRH French Reference Center for Hemophilia Lyon
-
Jun 2, 2026, 19:27Francisco Chacón-Lozsán: Coma Is Not a Diagnosis – Final Pathway Of Brain Arousal And Awareness Failure
-
Jun 2, 2026, 19:26Panagiotis Papanagiotou: Recognizing CVST On T2 MRI
-
Jun 2, 2026, 17:56Coralie Delporte Gravouil: Scientific Program 2026 – Essentials of Hemostasis Now Available
-
Jun 2, 2026, 17:55Anna Rivera: Hemophilia Management – A Shift from Traditional IV Therapies to Novel Subcutaneous Agents
-
Jun 2, 2026, 17:53Zoya Surayya: My Thesis on Anticoagulation After Ischemic Stroke